Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Colorectal Neoplasms and RNF43[original query] |
|---|
| Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer. Pharmacological research 2020 6 159 105028. Lin Anqi, Zhang Hongman, Hu Xigang, Chen Xiaoting, Wu Gang, Luo Peng, Zhang Ji |
| APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers. Cancers 2020 May 12 (5): . Fennell Lochlan J, Kane Alexandra, Liu Cheng, McKeone Diane, Fernando Winnie, Su Chang, Bond Catherine, Jamieson Saara, Dumenil Troy, Patch Ann-Marie, Kazakoff Stephen H, Pearson John V, Waddell Nicola, Leggett Barbara, Whitehall Vicki L |
| RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer. Oncology reports 2020 Mar . Matsumoto Akio, Shimada Yoshifumi, Nakano Mae, Oyanagi Hidehito, Tajima Yosuke, Nakano Masato, Kameyama Hitoshi, Hirose Yuki, Ichikawa Hiroshi, Nagahashi Masayuki, Nogami Hitoshi, Maruyama Satoshi, Takii Yasumasa, Ling Yiwei, Okuda Shujiro, Wakai Toshifu |
| Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy. Frontiers in oncology 2020 4 10 466. Cao Hua, Liu Xinyi, Chen Yixin, Yang Pan, Huang Tanxiao, Song Lele, Xu Ruili |
| Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum. PloS one 2020 15 (2): e0229262. Nakanishi Hiroyoshi, Sawada Takeshi, Kaizaki Yasuharu, Ota Ryosuke, Suzuki Hiromu, Yamamoto Eiichiro, Aoki Hironori, Eizuka Makoto, Hasatani Kenkei, Takahashi Naoki, Inagaki Satoko, Ebi Masahide, Kato Hiroyuki, Kubota Eiji, Kataoka Hiromi, Takahashi Satoru, Tokino Takashi, Minamoto Toshinari, Sugai Tamotsu, Sasaki Yasus |
| Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer. The oncologist 2020 Nov . Wang Chongkai, Ouyang Ching, Cho May, Ji Jingran, Sandhu Jaideep, Goel Ajay, Kahn Michael, Fakih Marw |
| Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer. Frontiers in oncology 2020 10 568911. Xu Ting, Zhang Yinjie, Zhang Jing, Qi Changsong, Liu Dan, Wang Zhenghang, Li Yanyan, Ji Congcong, Li Jian, Lin Xuan, Hou Ting, Liu Hao, Zhang Lu, Han-Zhang Han, Shen Lin, Wang Xiche |
| RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps. Histopathology 2020 Oct . van Herwaarden Yasmijn J, Koggel Lieke M, Simmer Femke, Vink-Börger Elisa M, Dura Polat, Meijer Gerrit A, Nagengast Fokko M, Hoogerbrugge Nicoline, Bisseling Tanya M, Nagtegaal Iris |
| RNF43 pathogenic Germline variant in a family with colorectal cancer. Clinical genetics 2021 9 101 (1): 122-126. Mikaeel Reger R, Young Joanne P, Li Yun, Poplawski Nicola K, Smith Eric, Horsnell Mehgan, Uylaki Wendy, Tomita Yoko, Townsend Amanda R, Feng Jinghua, Zibat Arne, Kaulfuß Silke, Müller Christian, Yigit Gökhan, Wollnik Bernd, Scott Hamish, Rawlings Lesley, Henry Denae, Vakulin Cassandra, Dubowsky Andrew, Price Timothy |
| Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer. Gastroenterology 2021 4 161 (2): 592-607. Rajamäki Kristiina, Taira Aurora, Katainen Riku, Välimäki Niko, Kuosmanen Anna, Plaketti Roosa-Maria, Seppälä Toni T, Ahtiainen Maarit, Wirta Erkki-Ville, Vartiainen Emilia, Sulo Päivi, Ravantti Janne, Lehtipuro Suvi, Granberg Kirsi J, Nykter Matti, Tanskanen Tomas, Ristimäki Ari, Koskensalo Selja, Renkonen-Sinisalo Laura, Lepistö Anna, Böhm Jan, Taipale Jussi, Mecklin Jukka-Pekka, Aavikko Mervi, Palin Kimmo, Aaltonen Lauri |
| An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report. Frontiers in oncology 2021 12 11 755578. Fang Tian, Liang Tingting, Wang Yizhuo, Wu Haitao, Liu Shuhan, Xie Linying, Zhang Zhihao, Liang Jiaying, Yao Cheng, Tan Yehui, Wang Cha |
| The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer. Cancers 2021 10 13 (20): . Frostberg Erik, Petersen Annabeth Høgh, Bojesen Anders, Rahr Hans Bjarke, Lindebjerg Jan, Rønlund Kari |
| Survey of Germline Variants in Cancer-Associated Genes in Young Adults with Colorectal Cancer. Genes, chromosomes & cancer 2021 Nov . Mikaeel Reger R, Young Joanne P, Li Yun, Smith Eric, Horsnell Mehgan, Uylaki Wendy, Tapia Rico Gonzalo, Poplawski Nicola K, Hardingham Jennifer E, Tomita Yoko, Townsend Amanda R, Feng Jinghua, Zibat Arne, Kaulfuß Silke, Müller Christian, Yigit Gökhan, Wollnik Bernd, Price Timothy |
| RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF metastatic colorectal cancer. Nature medicine 2022 9 28 (10): 2162-2170. Elez Elena, Ros Javier, Fernández Jose, Villacampa Guillermo, Moreno-Cárdenas Ana Belén, Arenillas Carlota, Bernatowicz Kinga, Comas Raquel, Li Shanshan, Kodack David Philip, Fasani Roberta, Garcia Ariadna, Gonzalo-Ruiz Javier, Piris-Gimenez Alejandro, Nuciforo Paolo, Kerr Grainne, Intini Rossana, Montagna Aldo, Germani Marco Maria, Randon Giovanni, Vivancos Ana, Smits Ron, Graus Diana, Perez-Lopez Raquel, Cremolini Chiara, Lonardi Sara, Pietrantonio Filippo, Dienstmann Rodrigo, Tabernero Josep, Toledo Rodrigo |
| Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer. Scientific reports 2022 Jul 12 (1): 13098. Siraj Abdul Khalid, Bu Rong, Masoodi Tariq, Parvathareddy Sandeep Kumar, Iqbal Kaleem, Al-Haqawi Wael, Al-Dossari Hassan, Azam Saud, Qadri Zeeshan, Annaiyappanaidu Padmanaban, Al-Dayel Fouad, Al-Kuraya Khawla Sa |
| Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors. Therapeutic advances in medical oncology 2022 6 14 17588359221105022. Xu Ting, Wang Xicheng, Wang Zhenghang, Deng Ting, Qi Changsong, Liu Dan, Li Yanyan, Ji Congcong, Li Jian, Shen L |
| Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer. British journal of cancer 2022 Jun . Hashimoto Taiki, Takayanagi Daisuke, Yonemaru Junpei, Naka Tomoaki, Nagashima Kengo, Yatabe Yasushi, Shida Dai, Hamamoto Ryuji, Kleeman Sam O, Leedham Simon J, Maughan Timothy, Takashima Atsuo, Shiraishi Kouya, Sekine Shige |
| Gene panel testing detects important genetic alterations in ulcerative colitis-associated colorectal neoplasia. Oncology letters 2022 11 24 (6): 442. Shimada Yoshifumi, Nakano Mae, Mizuno Ken-Ichi, Yokoyama Junji, Matsumoto Akio, Tanaka Kana, Oyanagi Hidehito, Nakano Masato, Hirose Yuki, Ichikawa Hiroshi, Sakata Jun, Kameyama Hitoshi, Takii Yasumasa, Sugai Mika, Ling Yiwei, Takeuchi Shiho, Okuda Shujiro, Terai Shuji, Ajioka Yoichi, Wakai Toshifu |
| Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2022 Sep 65 100883. Ye Liu-Fang, Huang Zi-Yao, Chen Xiao-Xi, Chen Zhi-Gang, Wu Si-Xian, Ren Chao, Hu Ming-Tao, Bao Hua, Jin Ying, Wang Feng, Wang Feng-Hua, Du Zi-Ming, Wu Xue, Ju Huai-Qiang, Shao Yang, Li Yu-Hong, Xu Rui-Hua, Wang De-Sh |
| Mutational landscape of circulating tumor DNA identifies distinct molecular features associated with therapeutic response in patients with metastatic colorectal cancer. Therapeutic advances in medical oncology 2022 14 17588359211070643. Shi Min, Yuan Hong, Ji Jun, Zhang Shouwei, Li Qingyuan, Chen Yawei, Gong Xiaoli, Zhu Zhenggang, Zhang J |
| RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer. Frontiers in oncology 2023 7 13 1119587. Peipei Shang, Jiongjiong Lu, Feihong Song, Yijun Zhao, Weipeng Hong, Yuange He, Weidong Shen, Li Ge |
| Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. Cancer science 2023 5 . Dai Shida, Aya Kuchiba, Tatsuhiro Shibata, Tetsuya Hamaguchi, Satoshi Yamasaki, Masaaki Ito, Takaya Kobatake, Toru Tonooka, Tadahiko Masaki, Manabu Shiozawa, Yasumasa Takii, Hiroyuki Uetake, Shu Okamura, Hitoshi Ojima, Shinsuke Kazama, Hiroshi Takeyama, Keisuke Kanato, Yasuhiro Shimada, Yoshinori Murakami, Yukihide Kanemit |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
| RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. American journal of cancer research 2023 12 13 (11): 5549-5558. Kaibin Huang, Shunkai Ding, Kai Chen, Chunhua Guo, Mingyi Wu, Rui Zhang, Luolin Wang, Yuxiang Fu, Jinfeng Xiao, Xianming L |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. Journal of translational medicine 2024 7 22 (1): 646. Christin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, Vegar J Dagenborg, Ida S Frøysnes, Mette M Larsen, Ben Davidson, Stein G Larsen, Kjersti Flatma |
| Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. The oncologist 2024 6 . Madappa N Kundranda, Ariane C Kemkes, Mark C Evans, Cynthia A Flannery, David W Hall, Jess R Hoag, Nishitha Therala, Snehal G Thakkar, Jean-Paul De La |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer. Seminars in oncology 2024 12 . Laura Pala, Tommaso De Pas, Emilia Cocorocchio, Chiara Catania, Giovanni Ceresoli, Daniele Laszlo, Emma Zattarin, Giovanna Rossi, Fabio Confor |
| Analysis of actionable gene fusions in a large cohort of Chinese patients with colorectal cancer. Gastroenterology report 2024 10 12 goae092. Fu-Rong Kou, Jian Li, Zheng-Hang Wang, Ting Xu, Juan-Juan Qian, En-Li Zhang, Li-Jun Zhang, Lin Shen, Xi-Cheng Wa |
- Page last reviewed:Feb 1, 2024
- Content source: